Trial
NCT05261711
AB1 in Adult Patients with Sickle Cell Disease (SCD)
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Nirmish Shah
Collaborators
—
Condition
Sickle Cell Disease
Intervention
AB1
Why stopped
Study is terminated prior to its planned completion as anticipated by the protocol due to enrollment completion. Data clean up and analysis is being performed.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-12-04